CNTB
Connect Biopharma Holdings Ltd
NASDAQ · Healthcare · Biotechnology · CN
$0.90
−0.72%Year over year
Reported trailing growth
- Revenue
- +293.7%
- EBITDA
- —
- EBIT
- —
- EPS
- -35.4%
- Free cash flow
- -10.9%
- Operating cash flow
- -13.3%
Forward estimates
Based on analyst estimates
- Revenue
- +245.7%
- EBITDA
- +58.5%
- EPS
- +59.7%
Three-year CAGR
- Revenue
- -99.8%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026